References
- Zuarez-Easton S, Zafran N, Garmi G, et al. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017;9:81–88.
- de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37(5):387–397.
- Centers for Disease Control and Prevention, National Healthcare Safety Network. CDC/NHSN. Procedure-associated Module. Surgical Site Infection (SSI) Event. [Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf
- Olsen MA, Butler AM, Willers DM, et al. Attributable costs of surgical site infection and endometritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol. 2010;31(3):276–282.
- Recipon G, Piver É, Caille A, et al. Is procalcitonin increased in cases of invasive amoebiasis? A retrospective, observational study. Diagn Microbiol Infect Dis. 2015;83(4):395–399.
- Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435.
- Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the perioperative period. Eur J Anaesthesiol. 1998;15(2):202–209.
- Brocca A, Virzì GM, de Cal M, et al. Elevated levels of procalcitonin and interleukin-6 are linked with postoperative complications in cardiac surgery. Scand J Surg. 2017;106(4):318–324.
- Ren H, Wang G, Gu G, et al. Predictive value of procalcitonin in postoperative intra-abdominal infections after definitive operation of intestinal fistulae. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(5):524–529.
- Kawakita T, Landy HJ. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol. 2017;3:12.
- Müller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis. 2007;7:10.
- Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159(2):253–264.
- Linscheid P, Seboek D, Nylen ES, et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology. 2003;144(12):5578–5584.
- Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518.
- Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–R242.
- Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg. 2007;245(5):745–754.
- Markogiannakis H, Memos N, Messaris E, et al. Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction. Surgery. 2011;149(3):394–403.
- Hunziker S, Hügle T, Schuchardt K, et al. The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery. J Bone Joint Surg Am. 2010;92(1):138–148.
- Carboni GL, Fahrner R, Gazdhar A, et al. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J CardioThorac Surg. 2008;33(5):777–780.
- Nie H, Jiang D, Ou Y, et al. Procalcitonin as an early predictor of postoperative infectious complications in patients with acute traumatic spinal cord injury. Spinal Cord. 2011;49(6):715–720.
- Perrakis A, Yedibela S, Schellerer V, et al. Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc. 2010;42(10):4187–4190.
- Meynaar IA, Droog W, Batstra M, et al. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, IL-6, or LBP. Crit Care Res Pract. 2011;2011:594645.
- Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med. 1997;45(9):552–560.
- Hausfater P, Garric S, Ayed SB, et al. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis. 2002;34(7):895–901.
- Henriquez-Camacho C, Losa J. Biomarkers for sepsis. BioMed Res Int. 2014;2014:547818.
- Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31(6):1737–1741.
- Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34(7):1996–2003.
- Yu CW, Juan LI, Hsu SC, et al. Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med. 2013;31(6):935–941.
- Park JH, Kim DH, Jang HR, et al. Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. Crit Care. 2014;18(6):640.
- Santonocito C, De Loecker I, Donadello K, et al. C-reactive protein kinetics after major surgery. Anesth Analg. 2014;119(3):624–629.
- Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998;24(7):680–684.
- Oberhofer D, Rumenjak V, Lazić J, et al. Inflammatory indicators in patients after surgery of the large intestine. Acta Med Croat. 2006;60(5):429–433.
- Dias BH, Rozario AP, Olakkengil SA. Role of inflammatory markers as predictors of laparotomy in patients presenting with acute abdomen. J Surg. 2015;85(10):755–759.